[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"development-infant\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:development-infant":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,9,0,[8,43,71,99,119,161,188,216,249],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":42},"100555939","phase-4-caffeine-citrate-in-preterm-infants-at-risk-of-apnea-in-zambia-100555939",false,"NCT06518603","Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia","Randomized Controlled Trial of Caffeine Citrate in Preterm Infants at Risk of Apnea in Zambia","Inclusion Criteria:\n\nNewborns:\n\n1. 29 0\u002F7 to 33 6\u002F7 weeks GA (or with a birth weight 1.0 to 2.0 kg if pregnancy dating is unreliable) admitted to the UTH NICU,\n2. On methylxanthines with plans to discontinue on methylxanthine,\n3. Off oxygen therapy for \\>48 hours at the time of evaluation for eligibility,\n4. Receiving full daily feeds,\n5. Deemed stable and ready to go off caffeine as recommended by the Neonatologist\n6. 18+ years of age (parent)\n\nExclusion Criteria:\n\n1. Newborns with neuromuscular conditions affecting respiration,\n2. Major congenital malformations and genetic disorders,\n3. Unable to obtain parental or guardian consent","ALL","0 Days","12 Months",{"count":20,"type":21},340,"ESTIMATED","INTERVENTIONAL",[24],"PHASE4","The goal of this clinical trial is to learn if caffeine citrate prevents apneic events that result in sick visits in moderately preterm infants after discharge from the hospital. It will also learn if the use of caffeine leads to better developmental outcomes at 12 months of age.\n\nOur research questions are:\n\n1. Does continued treatment of moderately preterm newborns with caffeine citrate after hospital discharge prevent or decrease apneic events that result in sick visits?\n2. Will the continued use of caffeine citrate lead to improved developmental outcomes among infants at 12 months of age?\n\nResearchers will compare caffeine citrate to a placebo (a look-alike substance that contains no drug) to see if caffeine citrate prevents apneic spells which result in healthcare visits.\n\nParents of participants will:\n\n1. Administer caffeine citrate 20mg\u002Fkg\u002Fday or a placebo (equivalent volume of sterile water) orally every day for up to 28 days after hospital discharge\n2. Keep a diary of symptoms and any apneic events\n3. Check in with researchers via telephone call once a week\n4. Return to clinic for infant physical examination at 28 days\n5. Return to the clinic for infant physical examination at 2 months\n\n5\\. Return to clinic for infant neurodevelopmental examination with Ages and Stages Questionnaire at 12 months of age",[27,28,29],"Premature Infant Disease","Apnea of Prematurity","Development, Infant","RECRUITING","2026-06-18",{"date":33,"type":34},"2026-06-23","ACTUAL",{"date":36,"type":34},"2026-06-17",{"date":38,"type":21},"2027-06-30",{"name":40,"class":41},"University of Alabama at Birmingham","OTHER",1,{"id":44,"slug":45,"hasResults":11,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":49,"eligibilityCriteria":50,"healthyVolunteers":11,"sex":16,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":4,"studyType":22,"phases":55,"briefSummary":57,"conditions":58,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":42},"100456946","sensory-optimization-of-the-hospital-environment-100456946","NCT05230199","Sensory Optimization of the Hospital Environment","Multisensory Interventions to Improve Neurodevelopmental Outcomes of Preterm Infants Hospitalized in the Neonatal Intensive Care Unit","SOOTHE","Inclusion Criteria:\n\n* ≤ 32 weeks estimated gestational age (EGA)\n* recruited within the first week of life\n\nExclusion Criteria:\n\n* \\> 32 weeks EGA at birth\n* \\>7 days old\n* become wards of the state\n* have a suspected or confirmed congenital anomaly\n* face a high immediate threat of death, per the opinion of the attending physician.","1 Day","7 Days",{"count":54,"type":21},215,[56],"NA","The long-term goal of this project is to improve the health and well-being of preterm infants and their parents. Although there is evidence to support positive multisensory interventions in the NICU, these interventions are often applied in an inconsistent manner, reducing their benefit. Through a rigorous and scientific process, we have developed a structured multisensory intervention program, titled Supporting and Enhancing NICU Sensory Experiences (SENSE), which includes specific doses and targeted timing of evidence-based interventions such as massage, auditory exposure, rocking, holding, and skin-to-skin care. The interventions are based on the infant's developmental stage and are adapted based on the infant's medical status and behavioral cues. The multisensory interventions are designed to be conducted during each day of NICU hospitalization by the parents, who are educated and supported to provide them. The proposed work aims to determine the effect of multisensory interventions on parent mental health, parent-child interaction, brain activity (amplitude integrated electroencephalography), and infant developmental outcomes through age 2 years, with specific attention to language outcome.",[59,60,61,29,62],"Preterm","Parent-Child Relations","Parents","Sensory Integration Dysfunction","2026-06-15",{"date":36,"type":34},{"date":66,"type":34},"2023-05-29",{"date":68,"type":21},"2028-12-31",{"name":70,"class":41},"University of Southern California",{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":76,"acronym":4,"eligibilityCriteria":77,"healthyVolunteers":78,"sex":79,"minAge":80,"maxAge":4,"enrollmentInfo":81,"targetDuration":4,"studyType":22,"phases":83,"briefSummary":84,"conditions":85,"keywords":4,"overallStatus":89,"whyStopped":4,"lastUpdateSubmitDate":90,"lastUpdatePostDateStruct":91,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":4},"100508541","phase-4-effect-of-iodine-containing-multiple-micronutrient-during-lactation-on-infant-neurodevelopment-100508541","NCT05901766","Effect of Iodine-containing Multiple Micronutrient During Lactation on Infant Neurodevelopment","Effect of Maternal Supplementation With an Iodine-containing Multiple Micronutrient During Lactation on Infant Iodine Status, Thyroid Function and Neurodevelopment","To be eligible, women will be required to meet the following inclusion criteria:\n\n* Maternal age 18 years or above, singleton pregnancy,\n* data available on Last Menstrual Period (LMP) or early ultrasound,\n* Intention to exclusively feed breastmilk for 4 to 6 months,\n* Intention to stay in the study catchment area for at least 6 months,\n* Willingness to take a daily supplement of MMS for 6 months\n\nExclusion criteria include:\n\n* Severe maternal morbidity (postpartum eclampsia, postpartum hemorrhage),\n* Maternal condition leading to inability for infant to directly\u002Fexclusively breastfeed (maternal mastectomy, or other breast surgery),\n* Breast cancer,\n* Tuberculosis",true,"FEMALE","18 Years",{"count":82,"type":21},600,[24],"The goal of this clinical trial is to learn about the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers who live in settings with mild iodine deficiency.\n\nThe main questions it aims to answer are:\n\n1. What are the effects of iodine-containing multiple micronutrient supplements provided to breastfeeding mothers on infant development, as measured by electroencephalography\u002Fvisual evoked potentials?\n2. What are the effects of iodine-containing multiple micronutrient supplements on breast milk concentrations of iodine, and infant iodine and thyroid status?\n3. How do iodine and iron interact with each other to affect thyroid function in the mother during lactation?\n\nParticipants will be randomized to receive a daily multiple micronutrient tablet containing iodine (UNIMAPP) for 6 months postpartum, or routine postnatal care per Ethiopia Ministry of Health. Mothers will provide a breast milk sample and blood at 3 and 6 months postpartum. Infants will provide a urine sample and drop of blood, and have a neurodevelopmental assessment at 3 and 6 months.\n\nResearchers will compare the groups that received the iodine-containing micronutrient supplement with the group that received routine care and see if there were any benefits on infant development and iodine and thyroid status in the mother and baby.",[86,87,29,88],"Iodine Deficiency","Nutrition Poor","Breastfeeding","NOT_YET_RECRUITING","2026-05-21",{"date":92,"type":34},"2026-05-26",{"date":94,"type":21},"2026-05-01",{"date":96,"type":21},"2028-03-31",{"name":98,"class":41},"Brown University",{"id":100,"slug":101,"hasResults":11,"nctId":102,"briefTitle":103,"officialTitle":103,"acronym":4,"eligibilityCriteria":104,"healthyVolunteers":78,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":105,"targetDuration":4,"studyType":22,"phases":107,"briefSummary":108,"conditions":109,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":112,"completionDateStruct":114,"leadSponsor":116,"locationsCount":118},"100504062","brain-organization-development-and-response-to-intervention-in-individual-neonates-100504062","NCT05843396","Brain Organization, Development, and Response to Intervention in Individual Neonates","Inclusion Criteria:\n\n* English speaking\n* Ability to give informed consent\n\nExclusion Criteria:\n\n* Prisoners (vulnerable population)\n* Pregnant women \\\u003C18 years of age\n* Active psychosis, mania, suicidal ideation (safety)\n* Active substance dependence\n* Gestational Age \\\u003C35 weeks (neonates)\n* Neonatal encephalopathy (neonates)",{"count":106,"type":21},80,[56],"The goal of this study is to learn about brain connectivity and if massaging babies shortly after birth has an impact. Half of the recruited babies will receive massage daily while the other half will not, and differences will be observed.",[29],"2026-04-29",{"date":94,"type":34},{"date":113,"type":34},"2025-03-31",{"date":115,"type":21},"2030-07",{"name":117,"class":41},"Washington University School of Medicine",2,{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":123,"acronym":124,"eligibilityCriteria":125,"healthyVolunteers":78,"sex":16,"minAge":126,"maxAge":127,"enrollmentInfo":128,"targetDuration":4,"studyType":130,"phases":4,"briefSummary":131,"conditions":132,"keywords":135,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":152,"lastUpdatePostDateStruct":153,"startDateStruct":155,"completionDateStruct":157,"leadSponsor":159,"locationsCount":42},"100546559","neuroimaging-of-babies-during-natural-sleep-to-assess-typical-development-and-cerebral-palsy-100546559","NCT06396520","Neuroimaging of Babies During Natural Sleep to Assess Typical Development and Cerebral Palsy","NIBS-CP","Inclusion Criteria High-Risk population:\n\nGroup: 'Newborn-detectable risk-pathway'\n\n* Preterm birth with gestational age below 32 weeks\n* Birth weight below 1500 g\n* Moderate to severe brain injury (A label of moderate to severe brain injury was considered if there was Papile grade three to four intraventricular haemorrhage, cystic periventricular leukomalacia, neonatal stroke, term hypoxic-ischaemic encephalopathy (≥35 weeks gestation at birth) or other significant neurological condition)\n* History (e.g., neonatal seizures, ECMO, meningitis, kernicterus, severe hypoglycemia) or neurological risk factors (malformations in CNS, increased tone)\n\nGroup: 'Infant detectable risk-pathway'\n\n* Inability to sit independently by age 9 months\n* Hand function asymmetry or crawl asymmetry\n* Inability to take weight through the plantar surface of the feet\n* History (e.g., as above) or neurological risk factors\n\nAdditional inclusion criteria for inclusion in NIBS-CP for both CP-risk groups:\n\n\\- Consent to health-relevant information on clinical findings being passed on to the medical doctors in CP-EDIT and\u002For their primary care physician.\n\nInclusion Criteria Typically developing infant population:\n\n* Born \\>37 weeks\n* Uneventful birth\n* No known history of brain injury\n* No neurological condition\n* Consent to health-relevant information on clinical findings being passed on to their primary care physician or relevant medical doctors, e.g., neuropaediatrician.\n\nExclusion Criteria (all groups):\n\n* Infants have any MRI contraindications, e.g., pacemaker or other implanted electronic devices.\n* Families do not speak or understand Danish.\n* Families do not wish to be informed about incidental findings on the MRI, or scores within the clinical range in the neurological, motor, or cognitive assessments.","2 Months","11 Months",{"count":129,"type":21},200,"OBSERVATIONAL","Background: Early diagnosis of cerebral palsy (CP) is crucial, enabling intervention when neuroplasticity is at its highest. Magnetic resonance imaging (MRI) plays a vital role in CP diagnosis. Currently, diagnostic MRI of newborns and infants with suspected brain damage relies heavily on structural MR images. The current study aims to i) establish procedures for clinical infant and toddler MRI during natural sleep, ii) use advanced MRI sequences, such as advanced diffusion-weighted imaging (DWI), that may be more sensitive in detecting early brain damage, and iii) map relationships between early brain development, and motor function and development.\n\nMethods: The NIBS-CP study will enroll approximately 200 infants either at risk for CP or typically developing. Infants will be followed longitudinally (for three waves) between 3 months and 2 years of age with cerebral MRI at 3 Tesla and comprehensive assessments of motor and cognitive functioning. The MRI protocol includes advanced diffusion-weighted imaging, high-resolution structural MRI, and MR spectroscopy. The motor and cognitive assessments include Hand Assessment in Infants, Alberta Infant Motor Scales, Hammersmith Infant Neurological Examination, Peabody Developmental Motor Scales, Bayley Scales of Infant Development, and Ages and Stages Questionnaires. NIBS-CP aims to establish normative material on early brain development of Danish children and conduct normative modeling of typical and atypical development to identify deviations in brain development at the level of the single child.\n\nDiscussion: Identifying predictive brain structural features of motor function and motor development is key to the future use of early MRI in the clinical work-up, as this promotes early diagnosis and (clinical) intervention strategies tailored to the individual child.",[133,134,29],"Cerebral Palsy","Infant Development",[136,137,138,139,140,141,142,143,144,133,145,146,147,148,149,150,151],"MRI","Brain development","Diffusion MRI","Motor development","Cognitive development","Normative modelling","Hand assessment for infants","Alberta Infant Motor scale","Motor functioning","Typically developing","Infants","Toddlers","Children","Peabody Developmental Motor Scales","Corticospinal tract","Motor system","2026-01-27",{"date":154,"type":34},"2026-01-28",{"date":156,"type":34},"2024-06-01",{"date":158,"type":21},"2027-12-31",{"name":160,"class":41},"Danish Research Centre for Magnetic Resonance",{"id":162,"slug":163,"hasResults":11,"nctId":164,"briefTitle":165,"officialTitle":166,"acronym":4,"eligibilityCriteria":167,"healthyVolunteers":78,"sex":16,"minAge":168,"maxAge":4,"enrollmentInfo":169,"targetDuration":4,"studyType":22,"phases":171,"briefSummary":172,"conditions":173,"keywords":176,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":180,"lastUpdatePostDateStruct":181,"startDateStruct":183,"completionDateStruct":185,"leadSponsor":186,"locationsCount":118},"100503411","hands-and-hearts-together-100503411","NCT05834907","Hands and Hearts Together","Prevention of Attachment Insecurity, Physiological Dysregulation, and Child Behavior Problems","Inclusion Criteria:\n\n* Parents whose children (age 8 to 36 months) are enrolled or are eligible to be enrolled in Harrisburg PA and Lehigh Valley PA Early Head Start programs\n\nExclusion Criteria:\n\n* Parents who are not sufficiently fluent in the language in which COS-P intervention will be conducted (Spanish or English)","8 Months",{"count":170,"type":21},249,[56],"Growing evidence demonstrates that secure attachment in childhood predicts children's healthy social, biological, and behavioral functioning, whereas insecure attachment predicts behavior problems and physiological dysregulation; thus, efforts to foster secure attachment are crucial for promoting the healthy development of children and families. This proposal describes a randomized controlled trial (RCT) of an innovative intervention program that can be widely implemented designed to foster children's secure attachment, promote healthy physiological regulation, and reduce the risk for behavior problems: The Circle of Security ® Parenting (COS-P) intervention. To this end, investigators will conduct an RCT with 249 parent-child dyads enrolled or are eligible but not yet enrolled in two diverse Early Head Start (EHS) programs.",[60,29,174,175],"Parenting","Development, Child",[60,29,174,175,177,178,179],"Attachment","Home Visiting","Early Intervention","2025-06-30",{"date":182,"type":34},"2025-07-03",{"date":184,"type":34},"2023-03-27",{"date":38,"type":21},{"name":187,"class":41},"University of Maryland, College Park",{"id":189,"slug":190,"hasResults":11,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":194,"eligibilityCriteria":195,"healthyVolunteers":11,"sex":79,"minAge":80,"maxAge":196,"enrollmentInfo":197,"targetDuration":4,"studyType":22,"phases":199,"briefSummary":200,"conditions":201,"keywords":203,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":207,"lastUpdatePostDateStruct":208,"startDateStruct":210,"completionDateStruct":212,"leadSponsor":214,"locationsCount":118},"100528202","social-transfers-for-exclusive-breastfeeding-in-brazil-100528202","NCT06157697","Social Transfers for Exclusive Breastfeeding in Brazil","Social Transfers for Exclusive Breastfeeding in São Paulo, Brazil","STEBB","Inclusion Criteria:\n\n* Gave birth in the last 72 hours\n* Exclusively breastfeeding at time of recruitment and intend to continue to exclusively breastfeed\n* Part of or eligible Bolsa Familia or on the Bolsa Familia list (CAD Unico)\n* Lives in São Paulo\n* No illnesses that contraindicates breastfeeding\n* Had a healthy singleton infant of 37 weeks or more gestation with a birth weight of at least 2500 grams\n* Agrees to participate and sign an informed consent; if under age (12-17 years), a legal representative will also have to agree to sign the informed consent\n\nExclusion Criteria:\n\n* Plans to move permanently outside study area\n* Has a medical, intellectual or psychological disability\n* Contraindication for breastfeeding\n* Preterm births\n* Children born with \\\u003C 2500 grams","50 Years",{"count":198,"type":21},400,[56],"The goal of this study is to assess the effectiveness of social transfers on exclusive breastfeeding rates in São Paulo, Brazil. The main research questions are:\n\n1. Are social transfers effective at increasing exclusive breastfeeding rates\n2. Are social transfers effective in prolonging the duration of exclusive breastfeeding\n3. Are social transfers effective in prolonging the duration of complementary breastfeeding\n4. What are the long-term impacts of social transfers for breastfeeding on child health and development\n\nParticipants will be randomly assigned to one of three groups: 1) control, no social transfer 2) non-conditional social transfer at 6-months postpartum, and 3) conditional social transfer at six months postpartum; conditional upon the mothers exclusive breastfeeding status.\n\nAll participants receive education about the benefits of exclusive breastfeeding and current international recommendations.\n\nResearchers will compare the intervention groups to the control group to see if social transfers are effective at increasing exclusive breastfeeding rates at six months postpartum.",[202,88,175,29],"Breast Feeding, Exclusive",[204,205,206],"exclusive breastfeeding","child development","social transfer","2025-06-18",{"date":209,"type":34},"2025-06-24",{"date":211,"type":34},"2025-03-06",{"date":213,"type":21},"2027-10",{"name":215,"class":41},"Swiss Tropical & Public Health Institute",{"id":217,"slug":218,"hasResults":11,"nctId":219,"briefTitle":220,"officialTitle":220,"acronym":221,"eligibilityCriteria":222,"healthyVolunteers":78,"sex":16,"minAge":223,"maxAge":224,"enrollmentInfo":225,"targetDuration":4,"studyType":130,"phases":4,"briefSummary":227,"conditions":228,"keywords":234,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":240,"lastUpdatePostDateStruct":241,"startDateStruct":243,"completionDateStruct":245,"leadSponsor":247,"locationsCount":42},"100479753","development-of-motility-and-cognition-in-infants-100479753","NCT05527080","Development of Motility and Cognition in Infants","PILKE","Inclusion Criteria:\n\n* age at enrollment 5-8mos\n* typically developing\n\nExclusion Criteria:\n\n* all neurologically significant medical histories during pregnancy, at birth or postnatally\n* suspicion of developmental delay\n* suspicion or diagnosis of syndromes with neuromotor symptoms","5 Months","26 Months",{"count":226,"type":21},250,"PILKE study uses wearables for assessing motor development in infants in order to define functional growth trajectories in the normal infants and infants at risk of neurological compromise. In addition, PILKE studies correlation of early motor development to later neurocognitive development.",[229,230,29,231,232,233],"Neurodevelopmental Disorders","Developmental Delay","Child Development","Cognitive Developmental Delay","Neurophysiologic Abnormality",[235,236,237,238,239],"wearable","medical wearable","human activity recognition","growth chart","neurodevelopment","2025-03-30",{"date":242,"type":34},"2025-04-03",{"date":244,"type":34},"2021-10-01",{"date":246,"type":21},"2027-12-30",{"name":248,"class":41},"Helsinki University Central Hospital",{"id":250,"slug":251,"hasResults":11,"nctId":252,"briefTitle":253,"officialTitle":254,"acronym":4,"eligibilityCriteria":255,"healthyVolunteers":78,"sex":16,"minAge":256,"maxAge":257,"enrollmentInfo":258,"targetDuration":4,"studyType":130,"phases":4,"briefSummary":260,"conditions":261,"keywords":4,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":265,"lastUpdatePostDateStruct":266,"startDateStruct":268,"completionDateStruct":270,"leadSponsor":272,"locationsCount":42},"100498206","early-neurophysiological-markers-of-language-impairments-100498206","NCT05767242","Early Neurophysiological Markers of Language Impairments","Early Neurophysiological Markers of Language Impairments: a Longitudinal Study on Infants At Familial Risk","Inclusion Criteria:\n\n* Healthy infants aged \\\u003C24 months\n* Infants with and without familial risk for language impairments (infants are assigned to the group with familial risk if at least one first-degree relative had a certified (clinical) diagnosis of language impairment or learning disability\n* Both parents are native-Italian speakers\n\nExclusion Criteria:\n\n* Gestational age \\\u003C 37 weeks and\u002For birth weight \\\u003C 2500 grams\n* APGAR scores at birth at 1' and 5' \\\u003C 7\n* Bayley Cognitive Score \\\u003C 7\n* Presence of certified diagnosis of intellectual deficiency, attention-deficit disorder, sensorial and neurological disorders, or autism within first-degree relative","6 Months","8 Years",{"count":259,"type":21},100,"The present project aims at identifying very early electrophysiological risk markers for language impairments. The long-term goals of the study include the characterization of learning developmental trajectories in children at high risk for language impairments. In this project, all the infants of the Medea BabyLab cohort are followed-up until school age. Since these infants have complete information on early electrophysiological markers, the final goal of the project is the characterization of their learning developmental trajectories and the construction of a multi-factor prognostic model that includes the neurophysiological processes underlying basic-level skills as potential biomarkers for predicting later reading and spelling skills.",[29,262,263,264],"Development, Language","Developmental Language Disorder","Learning Disabilities","2025-02-03",{"date":267,"type":34},"2025-02-05",{"date":269,"type":34},"2022-02-21",{"date":271,"type":21},"2026-12-31",{"name":273,"class":41},"IRCCS Eugenio Medea"]